Recent Progress on Apoptotic Activity of Triazoles

dc.authorscopusid56612061400
dc.authorscopusid55894906300
dc.authorwosidKüçükgüzel, Ş.Güniz/AAQ-8954-2021
dc.contributor.authorCikla-Suzgun, P.
dc.contributor.authorKucukguzel, S. G.
dc.date.accessioned2025-01-11T13:01:30Z
dc.date.available2025-01-11T13:01:30Z
dc.date.issued2021
dc.departmentFenerbahçe Universityen_US
dc.department-temp[Cikla-Suzgun, P.] Marmara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34854 Istanbul, Turkey; [Kucukguzel, S. G.] Fenerbahce Univ, Vocat Sch Hlth Serv, TR-34758 Istanbul, Turkeyen_US
dc.description.abstractApoptosis is often called programmed cell death and is defined as a self-directed cell destruction process. It is different from necrosis due to the activation of caspases during this process. Apoptosis is directly related to cancer progression and plays a vital role in carcinogenesis; all cytotoxic drugs and radiation therapy programs initiate apoptosis in tumor cells. Today, studies show that heterocyclic compounds that contain triazole functionality have anticancer activities; triazoles are 5 membered rings, which contain two carbon and three nitrogen atoms. Therefore, many researchers have synthesized these small active compounds as target structures and evaluated their apoptotic activities. The present review describes recent medicinal aspects of triazoles as anticancer agents that have been reported during the past few years. We hope that the bioactivity of triazole derivatives will be beneficial for the rational design of a new generation of small molecule drugs.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.citation5
dc.identifier.doi10.2174/1389450122666210208181128
dc.identifier.endpage1900en_US
dc.identifier.issn1389-4501
dc.identifier.issn1873-5592
dc.identifier.issue16en_US
dc.identifier.pmid33563153
dc.identifier.scopus2-s2.0-85121954796
dc.identifier.scopusqualityQ2
dc.identifier.startpage1844en_US
dc.identifier.urihttps://doi.org/10.2174/1389450122666210208181128
dc.identifier.urihttps://hdl.handle.net/20.500.14627/132
dc.identifier.volume22en_US
dc.identifier.wosWOS:000711465400004
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherBentham Science Publ Ltden_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectApoptosisen_US
dc.subjectTriazoleen_US
dc.subjectCanceren_US
dc.subjectCaspase-8en_US
dc.subjectCaspase-3en_US
dc.subjectBcl-2en_US
dc.subjectCytochrome Cen_US
dc.titleRecent Progress on Apoptotic Activity of Triazolesen_US
dc.typeReviewen_US
dspace.entity.typePublication

Files